Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States미국에서 유행성 타임라인이 시작될 때 COVID-19에 대한 약물 요법의 사용 및 안전성에 대한 다기관 점 유병률 평가Multicenter Study Published on 2021-03-182022-09-11 Journal: American journal of health-system pharmacy : AJHP [Category] SARS, 치료제, [키워드] addition ADR ADRS Adverse drug reaction Adverse drug reactions Adverse reaction Adverse reactions antagonist Asthma Characteristics clinical Clinical data clinical trial clinical trials combination therapy Community Comprehensive conducted coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 treatments drug reaction drug therapy enrolled evaluated hospital Hydroxychloroquine identify interleukin interleukin-6 lAbel medication medication safety medications mitigate Most patient Most patients multicenter observational study occurred Odds ratio off-label pandemic Patient patients patients hospitalized patients treated patients with COVID-19 point prevalence Prevalence prevalence study random Random sample receiving Remdesivir SARS-CoV-2 supported supportive care the United State Therapies therapy treated Treatment while [DOI] 10.1093/ajhp/zxaa426 PMC 바로가기 [Article Type] Multicenter Study
Analysis of the prophylactic effect of thymosin drugs on COVID-19 for 435 medical staff: A hospital-based retrospective studyArticle Published on 2021-03-012023-07-06 Journal: Journal of medical virology [Category] SARS, [키워드] ADR COVID-19 Prophylactic SARS-CoV-2 thymosin drugs. [DOI] 10.1002/jmv.26492
Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactionsObservational Study Published on 2020-12-232022-10-04 Journal: Internal and Emergency Medicine [Category] MERS, SARS, 임상, [키워드] addition ADR ADRS Adverse drug reaction Adverse drug reactions age Caucasian patient Characteristics Clinical characteristics collected Comorbidities COVID-19 COVID-19 patient disorders drug–drug interaction Drug–drug interactions drugs effective evaluated Evidence Florence hospitalised hospitalised patient Hospitalised patients identify Interaction interactions internal medicine Italy less majority males medications outcome patients pharmacokinetic pharmacological pharmacovigilance preferred term Psychiatric QT interval QT prolongation reported resolved risk SARS-CoV-2 study period supplementary material treatments for COVID-19 unit university [DOI] 10.1007/s11739-020-02586-8 PMC 바로가기 [Article Type] Observational Study
Preliminary findings from stimulated spontaneous reporting of adverse drug reactions during COVID-19 pandemic: an experience from GhanaOriginal Article Published on 2020-12-012022-10-31 Journal: Ghana Medical Journal [Category] COVID-19, SARS, [키워드] accounted acute respiratory syndrome ADR Adverse drug reaction appear caused Characteristics classification coronavirus country COVID-19 COVID-19 pandemic COVID-19, pandemic drug Dyspnoea expected Frequency funding Healthcare professional Hydroxychloroquine information male medication micturition novel coronavirus disease objective Pain pandemic reported Result retrieved risk Sample size SARS-CoV-2 SARS-CoV-2 positive patient SARS-CoV-2 positive patients spontaneous reporting stimulated System term Treatment [DOI] 10.4314/gmj.v54i4s.10 PMC 바로가기 [Article Type] Original Article
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports개별 사례 안전성 보고서의 글로벌 데이터베이스에서 보고된 COVID-19 약물에 대한 보고된 약물 부작용의 성별 차이Article Published on 2020-12-012022-09-11 Journal: Drug safety [Category] 신약개발, 진단, 치료제, [키워드] (azithromycin abdominal pain acute respiratory syndrome acute respiratory syndrome coronavirus ADR ADRS Adverse Adverse drug reaction Algorithm Azithromycin Chloroquine clinical trial Combination coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19-specific treatment COVID-19-specific treatments database diarrhoea difference drug drug reaction drugs Effectiveness electrocardiogram evaluate event females fixed Frequency Health Organization Hepatitis Hydroxychloroquine identify indication indications individual International investigated Lopinavir Lopinavir/ritonavir male males nausea Non-COVID-19 Numerous Other pandemic pattern performed reaction Remdesivir remdesivir) renal report reported respiratory review Ritonavir Safety Sex Sex difference solidarity the disease therapeutic Treatment treatment of COVID-19 Trial vomiting World Health Organization Wuhan Wuhan, China [DOI] 10.1007/s40264-020-01000-8 PMC 바로가기 [Article Type] Article
Adverse drug reactions triggered by the common HLA-B*57:01 variant: virtual screening of DrugBank using 3D molecular dockingResearch Article Published on 2018-01-302024-09-02 Journal: Journal of Cheminformatics [Category] 대상포진, [키워드] abacavir ADR DrugBank HLA HLA-B57:01 molecular docking Virtual screening [DOI] 10.1186/s13321-018-0257-z PMC 바로가기 [Article Type] Research Article
Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergyReview Published on 2014-01-012023-06-02 Journal: The journal of allergy and clinical immunology. In [Category] 두창, [키워드] abacavir ABC Acute generalized exanthematous pustulosis ADR Adverse drug reaction AGEP bid Carbamazepine CBZ CMV CTL cytomegalovirus Cytotoxic lymphocyte DIHS DRESS DRESS-DIHS-HSS Drug reaction with eosinophilia and systemic symptoms Drug-induced hypersensitivity syndrome EBV Epstein-Barr virus HHV HLA HSR HSS human herpesvirus human leukocyte antigen hypersensitivity reaction Hypersensitivity syndrome INF-γ interferon gamma nonsteroidal anti-inflammatory drug NSAID Orally PBMC Peripheral blood mononuclear cell po. scar Severe cutaneous adverse drug reaction SJS SJS-TEN Steven-Johnson syndrome T-cell receptor TCR TEN Toxic epidermal necrolysis twice a day viral reactivation [DOI] 10.1016/j.jaip.2013.11.005 PMC 바로가기 [Article Type] Review